Given that circUCK2(2,3)-mediated EGFR activation leads to downstream activation of AKT and ERK signaling, which in turn enhances HCC cell proliferation, migration, and invasion, we next examined whether combined treatment with lenvatinib and pelitinib could impact these pathways. This evidence concerns the gene EGFR and hepatocellular carcinoma.